bioMérieux Share Price Euronext Paris
Stocks
FR0010096479
Medical Equipment, Supplies & Distribution
OTC Markets Traded| Market Cap | 8.48B 9.86B 7.98B 7.28B 13.59B 935B 13.66B 94.52B 36.57B 478B 37.03B 36.23B 1,521B | P/E 2026 * |
17.6x | P/E 2027 * | 16x |
|---|---|---|---|---|---|
| Enterprise Value | 8.07B 9.39B 7.59B 6.93B 12.93B 890B 13B 89.98B 34.81B 455B 35.25B 34.48B 1,448B | EV / Sales 2026 * |
1.96x | EV / Sales 2027 * | 1.79x |
| Free-Float |
33.22% | Yield 2026 * |
1.45% | Yield 2027 * | 1.6% |
Last Transcript : bioMérieux
| 1 day | -0.27% |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 30/06/2023 |
| Director of Finance/CFO | 50 | 28/02/2018 | |
| Chief Tech/Sci/R&D Officer | - | 31/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 14/12/2017 | |
| Director/Board Member | 66 | 31/12/2004 | |
| Director/Board Member | 61 | 29/05/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.27% | +1.25% | - | - | 9.86B | |
| +2.89% | +1.34% | +178.00% | +395.19% | 21.6B | |
| -0.49% | -5.16% | -37.33% | -22.13% | 9.86B | |
| +1.60% | +8.16% | +393.93% | +38.92% | 8.55B | |
| +0.36% | -0.26% | -27.14% | - | 7.01B | |
| +0.31% | +0.03% | +83.11% | +54.31% | 6.56B | |
| -1.42% | -3.08% | -27.94% | -20.49% | 5.84B | |
| +0.52% | -3.12% | -9.80% | -20.29% | 4.24B | |
| -2.77% | -5.58% | +65.48% | +79.79% | 4.2B | |
| -0.53% | -3.11% | -24.32% | -30.15% | 2.74B | |
| Average | +0.07% | -0.92% | +66.00% | +59.39% | 7.84B | |
| Weighted average by Cap. | +0.73% | -0.87% | +102.02% | +142.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.12B 4.8B 3.88B 3.54B 6.61B 455B 6.64B 45.97B 17.79B 232B 18.01B 17.62B 740B | 4.34B 5.04B 4.08B 3.72B 6.95B 478B 6.99B 48.35B 18.71B 244B 18.94B 18.53B 778B |
| Net income | 482M 561M 454M 414M 773M 53.19B 777M 5.38B 2.08B 27.19B 2.11B 2.06B 86.51B | 525M 611M 494M 451M 842M 57.92B 846M 5.86B 2.27B 29.6B 2.29B 2.24B 94.21B |
| Net Debt | -408M -474M -384M -350M -653M -44.95B -657M -4.54B -1.76B -22.98B -1.78B -1.74B -73.11B | -731M -850M -688M -628M -1.17B -80.63B -1.18B -8.15B -3.15B -41.21B -3.19B -3.12B -131B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
